[1,4'-Bipiperidine]-4'-carboxamide

Catalog No.: 
ACNUVC923
CAS No.: 
39633-82-4
Molecular Formula: 
C11H21N3O
Molecular Weight: 
211.31
[1,4'-Bipiperidine]-4'-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$188.00In stockInquiry
250mg95%$341.00InquiryInquiry
1g95%$822.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name[1,4'-Bipiperidine]-4'-carboxamide
IUPAC Name[1,4'-bipiperidine]-4'-carboxamide
MDL No.MFCD01631148
Molecular FormulaC11H21N3O
Molecular Weight211.31
SMILESO=C(C1(N2CCCCC2)CCNCC1)N
InChI KeyAUXZEVXPRCVGAO-UHFFFAOYSA-N
Synonym(1,4'-BIPIPERIDINE)-4'-CARBOXAMIDE;4-(1-PIPERIDINO)-4-PIPERIDINECARBOXAMIDE;(1,4'-Bipiperidine)-4'-carboxamide, 99+%;4-piperidin-1-ylpiperidine-4-carboxamide;4-piperidinoisonipecotamide;4-(1-Piperidinyl)-4-(aMinocarbonyl)piperidine;4-CarbaMoyl-4-(1-piperidinyl)piperidine;NSC 76044
CAS No.39633-82-4
PubChem CID96486

Safety Data

Pictogram
Corrosive
Signal Word
Gefahr
Hazard Statement(s)
H314
Precautionary Statement(s)
P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P321-P363-P405-P501

Synthetic Route by SureRoute

1. ACNUVC923 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKCOP059 route compound structure diagram
    ACKCOP0591762-50-1In Stock
  2. Then
  3. ACNUVC923 route product structure diagram
    ACNUVC92339633-82-4In Stock
Inquiry

2. ACNUVC923 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNUVC923 route product structure diagram
    ACNUVC92339633-82-4In Stock
Inquiry

3. ACNUVC923 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNUVC923 route product structure diagram
    ACNUVC92339633-82-4In Stock
Inquiry

Comments (0)